Evidence Library
Filter by drug, type, year, and open access.
Showing 1–3 of 3 results
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline — Journal of Clinical Sleep Medicine (2021)• Drug: sodium-oxybate-extended-releaseDOI
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment — Journal of Clinical Sleep Medicine (2021)• Drug: sodium-oxybate-extended-releaseDOI
- Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy — Sleep (2021)• Drug: sodium-oxybate-extended-releaseDOI